Correlates of unsafe syringe acquisition and disposal among injection drug users in Baltimore, Maryland

Substance Use and Misuse

Volumn 40, Issue 12, 2005, Pages 1751-1764

  Golub, Elizabeth T ^a   Bareta, Joseph C ^a,d   Mehta, Shruti H ^a   McCall, Lisa D ^a   Vlahov, David ^b   Strathdee, Steffanie A ^c  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b NEW YORK ACADEMY OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d Infectious Disease Bureau   (Mexico)

Author keywords

Epidemiology; Injection drug use; NEP; Syringe acquisition; Syringe disposal

Indexed keywords

COCAINE; METHADONE;

ADULT; AFRICAN AMERICAN; AGE; ARTICLE; DISPOSABLE EQUIPMENT; FEMALE; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; METHADONE TREATMENT; PRIORITY JOURNAL; SYRINGE; UNITED STATES; VIRUS TRANSMISSION;

ADOLESCENT; ADULT; BALTIMORE; COHORT STUDIES; FEMALE; HUMANS; MALE; MARYLAND; MEDICAL WASTE DISPOSAL; MIDDLE AGED; NEEDLE SHARING; NEEDLE-EXCHANGE PROGRAMS; PREVALENCE; RISK-TAKING; SUBSTANCE ABUSE, INTRAVENOUS; SYRINGES;

EID: 27544500903     PISSN: 10826084     EISSN: 15322491     Source Type: Journal    
DOI: 10.1080/10826080500259513     Document Type: Article

References (40)

1. Abdala, N., Stephens, P. C., Griffith, B. P., Heimer, R. (1999). Survival of HIV-1 in syringes. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 20(1):73-80.
2. Bastos, F. I., Strathdee, S. A. (2000). Evaluating effectiveness of syringe exchange programmes: current issues and future prospects. Soc. Sci. Med. 51(12):1771-1782.
3. Burris, S., Vernick, J. S., Ditzler, A., Strathdee, S. (2002). The legality of selling or giving syringes to injection drug users. J. Am. Pharm. Assoc. (Wash.) 42(6 Suppl 2):S13-S18.
4. Burris, S., Strathdee, S. A., Vernick, J. S. (2003). Lethal injections: the law, science and politics of syringe access for injection drug users. University of San Francisco Law Review 37:813.
5. Centers for Disease Control and Prevention. (2000). HIV/AIDS surveillance report. 12(2):12.
6. Coffin, P. O., Ahern, J., Dorris S., Stevenson, L., Fuller, C., Vlahov, D. (2001). More pharmacists in high-risk neighborhoods of New York City support selling syringes to injection drug users. J. Am. Pharm. Assoc. (Wash.) 42(6 Suppl 2):S62-S67.
7. Cotten-Oldenburg, N. U., Carr, P., DeBoer, J. M., Collison, E. K., Novotny, G. (2001). Impact of pharmacy-based syringe access on injection practices among injecting drug users in Minnesota, 1998 to 1999. J. Acquir. Immune. Defic. Syndr. 27(2):183-192.
8. Des Jarlais, D. C., Hagan, H., Friedman, S. R., Friedmann, P., Goldberg, D., Frischer, M., Green, S., Tunving, K., Ljungberg, B., Wodak, A. (1995). Maintaining low HIV seroprevalence in populations of injecting drug users. JAMA 274(15):1226-1231.
9. Des Jarlais, D. C., Marmor, M., Paone, D., Titus, S., Shi, Q., Perlis, T., Jose, B., Friedman, S. R. (1996). HIV incidence among injecting drug users in New York City syringe-exchange programmes. Lancet 348(9033):987-991.
10. Des Jarlais, D. C., Friedman, S. R., Stoneburner, R. L. (1988). HIV infection and intravenous drug use: critical issues in transmission dynamics, infection outcomes, and prevention. Rev. Infect. Dis. 10(1):151-158.
11. Doherty, M. C., Garfein, R. S., Vlahov, D., Junge, B., Rathouz, P. J., Galai, N., Anthony, J. C., Beilenson, P. (1997). Discarded needles do not increase soon after the opening of a needle exchange program. Am. J. Epidemiol. 145:730-737.
12. Doherty, M. C., Junge, B., Rathouz, P. J., Garfein, R. S., Riley, E., Vlahov, D. (2000). The effect of a needle exchange program on numbers of discarded needles: a 2-year follow-up. Am. J. Public Health 90(6):936-939.
13. Donoghoe, M. C., Dolan, K. A., Stimson, G. V. (1992). Life-style factors and social circumstances of syringe sharing in injecting drug users. Br. J. Addict 87(7):993-l003.
14. Drucker, E., Lurie, P., Wodak, A., Alcabes, P. (1998). Measuring harm reduction: the effects of needle and syringe exchange programs and methadone maintenance on the ecology of HIV. AIDS 12: S217-S230.
15. Friedman, S. R., Jose, B., Deren, S., Des Jarlais, D. C., Neaigus, A. (1995). Risk factors for human immunodeficiency virus seroconversion among out-of-treatment drug injectors in high and low seroprevalence cities. Am. J. Epidemiol. 142:864-874.
16. Fuller, C. M., Ahern, J., Vadnai, L., Coffin, P. O., Galea, S., Factor, S. H., Vlahov, D. (2002). Impact of increased syringe access: preliminary findings on injection drug user syringe source, disposal, and pharmacy sales in Harlem, New York. J. Am. Pharm. Assoc. 42(6 Suppl 2):S77-S82.
17. Gleghorn, A. A., Jones, T. S., Doherty, M. C., Celentano, D. D., Vlahov, D. (1995). Acquisition and use of needles and syringes by injecting drug users in Baltimore, Maryland. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 10(1):97-103.
18. Gleghorn, A. A., Gee, G., Vlahov, D. (1998). Pharmacists' attitudes about pharmacy sale of needles/syringes and needle exchange programs in a city without needle/syringe prescription laws. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 18(Suppl 1):S89-S93.
19. Gleghorn, A. A., Wright-De Aguero, L., Flynn, C. (1998). Feasibility of one-time use of sterile syringes: a study of active injection drug users in seven United States metropolitan areas. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 18(Suppl 1):S30-S36.
20. Holmberg, S. D. (1996). The estimated prevalence and incidence of HIV in 96 large US metropolitan areas. Am. J. Public Health 86(5):642-654.
21. Kaplan, E. H., Khoshnood, K., Heimer, R. (1994). A decline in HIV-infected needles returned to New Haven's needle exchange program: client shift or needle exchange? Am. J. Public Health 84(12):1991-1994.
22. Kaplan, E. H., Heimer, R. (1995). HIV incidence among New Haven needle exchange participants: updated estimates from syringe tracking and testing data. J. Acquir. Immune. Defic. Syndr. Hum. Retrovirol. 10(2):175-176.
23. Klein, S. J., Harris-Valente, K., Candelas, A. R., Radigan, M., Narcisse-Pean, M., Tesoriero, J. M., Birkhead, G. S. (2001). What do pharmacists think about New York state's new nonprescription syringe sale program? Results of a survey. J. Urban Health 78(4):679-689.
24. Latkin, C. A., Forman, V. L. (2001). Patterns of needle acquisition and sociobehavioral correlates of needle exchange program attendance in Baltimore, Maryland, U.S.A. J. Acquir. Immune Defic. Syndr. 27(4):398-404.
25. Lewis, B. A., Koester, S. K., Bush, T. W. (2002). Pharmacists' attitudes and concerns regarding syringe sales to injection drug users in Denver, Colorado. J. Am. Pharm. Assoc. (Wash.) 42(6 Suppl 2):S46-S51.
26. Macalino, G. E., Springer, K. W., Rahman, Z. S., Vlahov, D., Jones, T. S. (1998). Community-based programs for safe disposal of used needles and syringes. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 18(Suppl 1):S111-S119.
27. Normand, J., Vlahov, D., Moses, L. E., Eds. (1995). Preventing HIV Transmission: The Role of Sterile Needles and Bleach. Washington, DC: National Academy Press.
28. Obadia, Y., Feroni, I., Perrin, V., Vlahov, D., Moatti, J.-P. (1999). Syringe vending machines for injection drug users: an experiment in Marseille, France. Am. J. Public Health 89:1852-1854.
29. Oliver, K. J., Friedman, S. R., Maynard, H., Magnuson, L., Des Jarlais, D. C. (1992). Impact of a needle exchange program on potentially infectious syringes in public places. J. Acquir. Immune. Defic. Syndr. 5(5):534-535.
30. Patrick, D. M., Strathdee, S. A., Archibald, C. P., Ofner, M., Craib, K. J., Cornelisse, P. G., Schechter, M. T., Rekart, M. L., O'Shaughnessy, M. V. (1997). Determinants of HIV seroconversion in injection drug users during a period of rising prevalence in Vancouver. Int. J. Std. AIDS 8(7):437-445.
31. Rich, J. D., Martin, E. G., Macalino, G. E., Paul, R. V., McNamara, S., Taylor, L. E. (2002). Pharmacist support for selling syringes without a prescription to injection drug users in Rhode Island. J. Am. Pharm. Assoc. (Wash.) 42(6 Suppl 2):S58-61.
32. Riley, E., Beilenson, P., Vlahov, D., Smith, L., Koenig, M., Jones, T. S., Doherty, M. (1998). Operation Red Box: a pilot project of needle and syringe drop boxes for injection drug users in East Baltimore. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 18(Suppl 1):S120-S125.
33. Sheridan, J., Lovell, S., Turnbull, P., Parsons, J., Stimson, G., Strang, J. (2000). Pharmacy-based needle exchange (PBNX) schemes in south east England: a survey of service providers. Addiction 95(10):1551-1560.
34. Springer, K. W., Sterk, C. E., Jones, T. S., Friedman, L. (1999). Syringe disposal options for injection drug users: a community-based perspective. Subst. Use Misuse 34(13):1917-1934.
35. Strathdee, S. A., Patrick, D. M., Archibald, C. P., Ofner, M., Cornelisse, P. G., Rekart, M., Schechter, M. T., O'Shaughnessy, M. V. (1997). Social determinants predict needle-sharing behaviour among injection drug users in Vancouver, Canada. Addiction 92(10):1339-1347.
36. Van Ameijden, E. J. C., Van Den Hoek, J. A. R., Coutinho, R. A. (1994). Injecting risk behaviour among drug users in Amsterdam, 1986 to 1992, and its relationship to AIDS prevention programs. Am. J. Public Health 84:275-281.
37. Vlahov, D., Muñoz, A., Anthony, J. C., Cohn, S., Celentano, D. D., Nelson, K. E. (1990). Association of drug injection patterns with antibody to human immunodeficiency virus type 1 among intravenous drug users in Baltimore, Maryland. Am. J. Epidemiol. 132:847-856.
38. Vlahov, D., Anthony, J. C., Munoz, A., Margolick, J., Nelson, K. E., Celentano, D. D., Solomon, L., Polk, B. F. (1991). The ALIVE study, a longitudinal study of HIV-1 infection in intravenous drug users: description of methods and characteristics of participants. NIDA Res. Monogr. 109:75-100.
39. Vlahov, D., Junge, B., Brookmeyer, R., Cohn, S., Riley, E., Armenian, H., Beilenson, P. (1997). Reductions in high-risk drug use behaviors among participants in the Baltimore needle exchange program. J. Acquir. Immune. Defic. Syndr. Hum. Retrovirol. 16:400-406.
40. Zeger, S. L., Liang, K. Y. (1986). Longitudinal data analysis for discrete and continuous outcomes. Biometrics 42:121-130.